| Serial Number | 90273166 |
| Word Mark | PLATELETBIO |
| Filing Date | Friday, October 23, 2020 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, June 5, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Platelets that are not bone marrow-derived, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, and admixtures, namely, extracellular vesicles or exosomes, all the foregoing for medical or clinical use; platelet variants for medical or clinical use; pharmaceutical and drug delivery compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; Pharmaceutical compositions for drug delivery comprising non bone marrow-derived platelets, platelet variants for treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; pharmaceutical compositions comprising platelet variants for transfusion in oncology, trauma and surgery; platelet variants for delivering proteins, antibodies, nucleic acids and other drugs to tumors, sites of vascular injury and inflammation, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; platelet variants as source for growth factors for medical or clinical use; compositions comprising viral vectors for medical or clinical use |
| Pseudo Mark | PLATELET BIO |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 11, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Platelet BioGenesis, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Watertown, MA 02472 |
| Event Date | Event Description |
| Tuesday, June 6, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, June 5, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, June 5, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Saturday, October 15, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, October 15, 2022 | NON-FINAL ACTION E-MAILED |
| Saturday, October 15, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 13, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 13, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 12, 2022 | ASSIGNED TO LIE |
| Thursday, April 7, 2022 | ASSIGNED TO LIE |
| Wednesday, April 6, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Saturday, October 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 8, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 8, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 8, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 8, 2021 | NON-FINAL ACTION E-MAILED |
| Thursday, April 8, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 24, 2021 | ASSIGNED TO EXAMINER |
| Friday, December 11, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 27, 2020 | NEW APPLICATION ENTERED |